Search

Satish Rampuria

Examiner (ID: 5875, Phone: (571)272-3732 , Office: P/2193 )

Most Active Art Unit
2193
Art Unit(s)
2191, 2193, 2124
Total Applications
1164
Issued Applications
972
Pending Applications
64
Abandoned Applications
143

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9805752 [patent_doc_number] => 20150017696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'RECOMBINANT HOST CELLS AND PROCESSES FOR PRODUCING 1,3-BUTADIENE THROUGH A CROTONOL INTERMEDIATE' [patent_app_type] => utility [patent_app_number] => 14/381157 [patent_app_country] => US [patent_app_date] => 2013-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22830 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381157 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/381157
RECOMBINANT HOST CELLS AND PROCESSES FOR PRODUCING 1,3-BUTADIENE THROUGH A CROTONOL INTERMEDIATE Feb 25, 2013 Abandoned
Array ( [id] => 9529769 [patent_doc_number] => 08753638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-17 [patent_title] => 'Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities' [patent_app_type] => utility [patent_app_number] => 13/766659 [patent_app_country] => US [patent_app_date] => 2013-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 63 [patent_no_of_words] => 43551 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13766659 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/766659
Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activities Feb 12, 2013 Issued
Array ( [id] => 8866039 [patent_doc_number] => 20130149743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'METHOD FOR ENHANCING LUMINESCENCE INTENSITY OF CLYTIN-II' [patent_app_type] => utility [patent_app_number] => 13/761173 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7958 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761173 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/761173
Method for enhancing luminescence intensity of clytin-II Feb 6, 2013 Issued
Array ( [id] => 8896517 [patent_doc_number] => 08476038 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-07-02 [patent_title] => 'Method for determining capability of a compound for inhibiting a receptor using codon-optimized nucleic acid' [patent_app_type] => utility [patent_app_number] => 13/761174 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7964 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761174 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/761174
Method for determining capability of a compound for inhibiting a receptor using codon-optimized nucleic acid Feb 6, 2013 Issued
Array ( [id] => 9793591 [patent_doc_number] => 20150005534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'CELLS AND METHODS FOR PRODUCING LUTEIN' [patent_app_type] => utility [patent_app_number] => 14/377041 [patent_app_country] => US [patent_app_date] => 2013-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26580 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14377041 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/377041
Cells and methods for producing lutein Feb 4, 2013 Issued
Array ( [id] => 12405285 [patent_doc_number] => 09968690 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-15 [patent_title] => Norbornene modified peptides and their labelling with tetrazine compounds [patent_app_type] => utility [patent_app_number] => 14/373292 [patent_app_country] => US [patent_app_date] => 2013-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 45 [patent_no_of_words] => 18240 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14373292 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/373292
Norbornene modified peptides and their labelling with tetrazine compounds Jan 20, 2013 Issued
Array ( [id] => 10083508 [patent_doc_number] => 09120847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Isolation of phosphoproteins, glycoproteins and fragments thereof' [patent_app_type] => utility [patent_app_number] => 13/744305 [patent_app_country] => US [patent_app_date] => 2013-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13512 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744305 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/744305
Isolation of phosphoproteins, glycoproteins and fragments thereof Jan 16, 2013 Issued
Array ( [id] => 10083508 [patent_doc_number] => 09120847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Isolation of phosphoproteins, glycoproteins and fragments thereof' [patent_app_type] => utility [patent_app_number] => 13/744305 [patent_app_country] => US [patent_app_date] => 2013-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13512 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13744305 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/744305
Isolation of phosphoproteins, glycoproteins and fragments thereof Jan 16, 2013 Issued
Array ( [id] => 9054613 [patent_doc_number] => 20130252327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'Methods Of Gene Amplification And Expression' [patent_app_type] => utility [patent_app_number] => 13/740694 [patent_app_country] => US [patent_app_date] => 2013-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6229 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13740694 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/740694
Methods Of Gene Amplification And Expression Jan 13, 2013 Abandoned
Array ( [id] => 8976643 [patent_doc_number] => 20130210073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'METHODS OF INCORPORATING AMINO ACID ANALOGS INTO PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/730116 [patent_app_country] => US [patent_app_date] => 2012-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 47631 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13730116 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/730116
Methods of incorporating amino acid analogs into proteins Dec 27, 2012 Issued
Array ( [id] => 9838999 [patent_doc_number] => 20150031081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'METHODS AND MATERIALS FOR REDUCING DEGRADATION OF RECOMBINANT PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/369324 [patent_app_country] => US [patent_app_date] => 2012-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10702 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14369324 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/369324
METHODS AND MATERIALS FOR REDUCING DEGRADATION OF RECOMBINANT PROTEINS Dec 27, 2012 Abandoned
Array ( [id] => 10932067 [patent_doc_number] => 20140335087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'ASPARTYL-TRNA SYNTHETASE-FC CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/368759 [patent_app_country] => US [patent_app_date] => 2012-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 59256 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 35 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14368759 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/368759
Aspartyl-tRNA synthetase-Fc conjugates Dec 26, 2012 Issued
Array ( [id] => 10946326 [patent_doc_number] => 20140349348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-27 [patent_title] => 'Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides' [patent_app_type] => utility [patent_app_number] => 14/365063 [patent_app_country] => US [patent_app_date] => 2012-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12560 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14365063 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/365063
Mutant microorganisms to synthesize colanic acid, mannosylated and/or fucosylated oligosaccharides Dec 13, 2012 Issued
Array ( [id] => 9785257 [patent_doc_number] => 20140302075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'ASPARTYL-TRNA SYNTHETASES' [patent_app_type] => utility [patent_app_number] => 14/360576 [patent_app_country] => US [patent_app_date] => 2012-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 46480 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360576 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/360576
Aspartyl-tRNA synthetases Dec 5, 2012 Issued
Array ( [id] => 12044762 [patent_doc_number] => 09822353 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'PEGylated aspartyl-tRNA synthetase polypeptides' [patent_app_type] => utility [patent_app_number] => 14/360573 [patent_app_country] => US [patent_app_date] => 2012-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 61057 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360573 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/360573
PEGylated aspartyl-tRNA synthetase polypeptides Dec 5, 2012 Issued
Array ( [id] => 10399722 [patent_doc_number] => 20150284731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'NUCLEOTIDE SEQUENCE AND A PROCESS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/434595 [patent_app_country] => US [patent_app_date] => 2012-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3821 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434595 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/434595
Nucleotide sequence and a process thereof Dec 4, 2012 Issued
Array ( [id] => 8733112 [patent_doc_number] => 20130078681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY HAVING ATTENUATED EXPRESSION OF GENES ENCODING A LYSINE/ARGININE/ ORNITHINE TRANSPORTER' [patent_app_type] => utility [patent_app_number] => 13/687353 [patent_app_country] => US [patent_app_date] => 2012-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8885 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13687353 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/687353
METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY HAVING ATTENUATED EXPRESSION OF GENES ENCODING A LYSINE/ARGININE/ ORNITHINE TRANSPORTER Nov 27, 2012 Abandoned
Array ( [id] => 8720661 [patent_doc_number] => 20130071878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-21 [patent_title] => 'TWO HELIX BINDERS' [patent_app_type] => utility [patent_app_number] => 13/682497 [patent_app_country] => US [patent_app_date] => 2012-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6621 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682497 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/682497
TWO HELIX BINDERS Nov 19, 2012 Abandoned
Array ( [id] => 8780694 [patent_doc_number] => 20130102669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'PERHYDROLASE VARIANT PROVIDING IMPROVED SPECIFIC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/657601 [patent_app_country] => US [patent_app_date] => 2012-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16953 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13657601 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/657601
Perhydrolase variant providing improved specific activity Oct 21, 2012 Issued
Array ( [id] => 10032923 [patent_doc_number] => 09074231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Reducing non-specific enzyme binding to enhance lignocellulose conversion' [patent_app_type] => utility [patent_app_number] => 13/652267 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 21 [patent_no_of_words] => 17999 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13652267 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/652267
Reducing non-specific enzyme binding to enhance lignocellulose conversion Oct 14, 2012 Issued
Menu